Pharma Pulse 9/3/24: CrowdStrike VP to Testify on IT Outage, Embracing FSPs & more

Embracing FSPs

Jenny Denney, executive vice president and head of FSP clinical and biometrics at Parexel, spoke with Pharmaceutical Executive about the growing use of functional service providers (FSPs) in the pharma industry. While these companies offer plenty of benefits, life sciences companies must also understand what they’re actually capable of to truly benefit from them.

Some Capculations: What the IRA Part D Out-of-Pocket Cost Cap Will Mean for Enrollees

Projections calculated for AARP show that 8.4% of Part D enrollees will benefit from the Inflation Reduction Act's $2,000 cap on out-of-pocket costs that goes into effect in 2025.

CrowdStrike VP Set to Testify to Congress on IT Outage

A senior member of CrowdStrike Holdings Inc.’s operations team is scheduled to appear before Congress on September 24th to answer questions on the company’s global IT outage in July that disrupted industries around the world.

UnitedHealthcare Awards $114,500 to Seven Organizations to Address Social Drivers of Health in Iowa

UnitedHealthcare has awarded $114,500 to seven organizations aimed at improving health outcomes across Iowa. The investments are part of UnitedHealthcare’s commitment to addressing the key social drivers that influence health and make a positive impact on the lives of underserved communities.

EAS Consulting Group, LLC on LinkedIn

In an interview with Pharmaceutical Commerce Magazine Editor Nicholas Saraceno, Jeb Hunter, Senior Regulatory Consultant, EAS Consulting Group, LLC, discusses the on “What to Expect When They’re Inspecting: FDA Inspections on DSCSA Compliance" breakout session at the 2024 HDA - Healthcare Distribution Alliance Traceability Seminar.

https://hubs.ly/Q02N5bQL0

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs